Truist Slashes Price Target on Keros Therapeutics to $43 From $100, Keeps Buy Rating

Truist将Keros Therapeutics的目标价格从100美元下调至43美元，维持买入评级。

MT Newswires · 03:52 · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.